Publications by authors named "Annie Castonguay"

This study aimed to evaluate natural antifungal agents for controlling food spoilage caused by Botrytis cinerea, Rhizopus stolonifer, and Alternaria brassicae. Various plant-derived essential oils (EOs), including Mediterranean, Pan Tropical, Greek, Canada pine, Nepal pine, clove bud, cumin, Moroccan, and others, as well as 2 citrus extracts, and spherical silver nanoparticles (AgNPs: AGPPH and AGC 0.5) were tested for their antifungal properties.

View Article and Find Full Text PDF

Ferroptosis is an iron-dependent lipid-peroxidation-driven mechanism of cell death and a promising therapeutic target to eradicate cancer cells. In this study, we discovered that boronic acid-derived salicylidenehydrazone (BASHY) dyes are highly efficient singlet-oxygen photosensitizers (PSs; Φ up to 0.8) that induce ferroptosis triggered by photodynamic therapy.

View Article and Find Full Text PDF

Activation of microglia in the spinal cord dorsal horn after peripheral nerve injury contributes to the development of pain hypersensitivity. How activated microglia selectively enhance the activity of spinal nociceptive circuits is not well understood. We discovered that after peripheral nerve injury, microglia degrade extracellular matrix structures, perineuronal nets (PNNs), in lamina I of the spinal cord dorsal horn.

View Article and Find Full Text PDF

Diels-Alder cycloadditions involving furans and maleimides are extensively used in organic chemistry and materials synthesis. Given the promising advances of organoruthenium complexes in therapy, we explored the possibility of exploiting such Diels-Alder linkages as a mean to modulate their biological properties.

View Article and Find Full Text PDF

and , two highly related species that might have emerged from a common commensal ancestor, constitute major human threats. Vaccines are available to prevent infection, whereas there are only a limited number of antibiotics available for Unfortunately, some strains of these species are rapidly evolving and capable of escaping human interventions. Thus, it is now urgent to develop new avenues to fight these bacteria.

View Article and Find Full Text PDF
Article Synopsis
  • * A study analyzed the genomes of 290 TN patients and found an increase in harmful genetic variants linked to GABA receptor-binding genes, suggesting a disruption in pain signaling.
  • * Additional findings also pointed to rare mutations in sodium and calcium channels, indicating that issues with ion transport might contribute to TN symptoms.
View Article and Find Full Text PDF

GABA/glycine-mediated neuronal inhibition critically depends on intracellular chloride (Cl) concentration which is mainly regulated by the K-Cl co-transporter 2 (KCC2) in the adult central nervous system (CNS). KCC2 heterogeneity thus affects information processing across CNS areas. Here, we uncover a gradient in Cl extrusion capacity across the superficial dorsal horn (SDH) of the spinal cord (laminae I-II: LI-LII), which remains concealed under low Cl load.

View Article and Find Full Text PDF

The Cu-catalyzed click conjugation of an azide-functionalized vitamin B (cobalamin) and an alkyne-labeled 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY) led to the formation of a highly stable fluorescent BODIPY-labeled vitamin B (λ/λ = 495/508 nm). The formation of what has been identified as an iodine adduct of the conjugate was also observed as a side-product during this reaction and could be removed using HPLC. BODIPY-labeled vitamin B was characterized by NMR and HR-ESI-MS.

View Article and Find Full Text PDF

Fungal infections, including those caused by antifungal-resistant Candida, are a very challenging health problem worldwide. Whereas different ruthenium complexes were previously studied for their anti-Candida potential, Ru-cyclopentadienyl complexes were overlooked. Here, we report an antifungal activity assessment of three Ru-cyclopentadienyl complexes with some insights into their potential mode of action.

View Article and Find Full Text PDF
Article Synopsis
  • - Ruthenium-based complexes, particularly Ru(II) cyclopentadienyl (Cp) complexes, show promise as alternatives to platinum drugs for treating breast cancer, specifically estrogen receptor positive (ER+) types.
  • - The Ru(II)Cp complex demonstrated high stability in lab conditions and showed significant cytotoxic effects in various breast cancer cell lines, unlike the common aromatase inhibitors anastrozole and letrozole on their own.
  • - Experiments on zebrafish embryos indicated that the Ru(II)Cp complex is non-toxic at effective treatment concentrations, highlighting its potential for further in vivo studies and for targeting triple negative breast cancer (TNBC).
View Article and Find Full Text PDF

Since the discovery of the anticancer potential of ruthenium-based complexes, several species were reported as promising candidates for the treatment of breast cancer, which accounts for the greatest number of new cases in women every year worldwide. Among these ruthenium complexes, species containing bioactive ligand(s) have attracted increasing attention due to their potential multitargeting properties, leading to anticancer drug candidates with a broader range of cellular targets/modes of action. This review of the literature aims at providing an overview of the rationally designed ruthenium-based complexes that have been reported to date for which ligands were carefully selected for the treatment of hormone receptor positive breast cancers (estrogen receptor (ER+) or progesterone receptor (PR+)).

View Article and Find Full Text PDF

Poor aqueous solubility is one of the recurrent drawbacks of many compounds in medicinal chemistry. To overcome this limitation, the dilution of drug candidates from stock solutions of an organic solvent is common practice. However, the precise characterisation of these compounds in aqueous solutions is often neglected, leading to some uncertainties regarding the nature of the actual active species.

View Article and Find Full Text PDF
Article Synopsis
  • Third-generation aromatase inhibitors like anastrozole and letrozole are important for treating ER+ breast cancers in postmenopausal women, and researching their metal coordination properties could help develop new cancer drugs.
  • A new ruthenium(II) arene complex incorporating anastrozole was synthesized and showed promising results, being the most stable in cell media and demonstrating high cellular uptake and cytotoxic effects on specific breast cancer cell lines.
  • This complex also reduced aromatase activity in certain cells and was not toxic to zebrafish embryos, suggesting it could be a good candidate for further research in cancer treatment.
View Article and Find Full Text PDF

In this study, five ruthenium arene complexes with fluorene-bearing N,N-(1) and N,O-(2) donor Schiff base ligands were synthesized and fully characterized. Cationic ruthenium complexes 3[X], ([Ru(η-CH)(Cl)(fluorene-N[double bond, length as m-dash]CH-pyridine)][X] (where X = BF, PF, BPh), were obtained by reacting ligand 1 with [Ru(η-CH)Cl] in the presence of NHX salts, whereas neutral complex 4, Ru(η-CH)(Cl)(fluorene-N[double bond, length as m-dash]CH-naphtholate), was isolated by reacting ligand 2 with the same precursor. It was possible to obtain a cationic version of the latter, 5[BF], by reacting 4 with AgBF in the presence of pyridine.

View Article and Find Full Text PDF

Neuropathic pain is a major incurable clinical problem resulting from peripheral nerve trauma or disease. A central mechanism is the reduced expression of the potassium chloride cotransporter 2 (KCC2) in dorsal horn neurons induced by brain-derived neurotrophic factor (BDNF), causing neuronal disinhibition within spinal nociceptive pathways. Here, we demonstrate how neurotensin receptor 2 (NTSR2) signaling impairs BDNF-induced spinal KCC2 down-regulation, showing how these two pathways converge to control the abnormal sensory response following peripheral nerve injury.

View Article and Find Full Text PDF

Metagenomic techniques, notably the cloning of environmental DNA (eDNA) into surrogate hosts, have given access to the genome of uncultured bacteria. However, the determination of gene functions based on DNA sequences alone remains a significant challenge. The functional screening of metagenomic libraries represents an interesting approach in the discovery of microbial metabolites.

View Article and Find Full Text PDF

The special ability of organometallic complexes to catalyze various transformations might offer new effective mechanisms for the treatment of cancer. Studies that report both the biological properties and the ability of metallic complexes to promote therapeutically relevant catalytic reactions are limited. Herein, we report the anticancer activity and catalytic potential of some ruthenium(II)-arene complexes bearing bidentate Schiff base ligands (2a and 2b) and their reduced analogues (5a and 5b, respectively).

View Article and Find Full Text PDF

Ru(II)-arene complexes are attracting increasing attention due to their considerable antitumoral activity. However, it is difficult to clearly establish a direct relationship between their structure and antiproliferative activity, as substantial structural changes might not only affect their anticancer activity but also tightly control their activation site(s) and/or their biological target(s). Herein, we describe the synthesis and characterization of four ruthenium(II) arene complexes bearing bidentate N,O-donor Schiff-base ligands ([Ru(η-benzene)(N-O)Cl]) that display a significantly distinct antiproliferative activity against cancer cells, despite their close structural similarity.

View Article and Find Full Text PDF

Cationic antimicrobial peptides (CAMPs) occur naturally in numerous organisms and are considered as a class of antibiotics with promising potential against multi-resistant bacteria. Herein, we report a strategy that can lead to the discovery of novel small CAMPs with greatly enhanced antimicrobial activity and retained antibiofilm potential. We geared our efforts towards i) the N-terminal cysteine functionalization of a previously reported small synthetic cationic peptide (peptide 1037, KRFRIRVRV-NH2), ii) its dimerization through a disulfide bond, and iii) a preliminary antimicrobial activity assessment of the newly prepared dimer against Pseudomonas aeruginosa and Burkholderia cenocepacia, pathogens responsible for the formation of biofilms in lungs of individuals with cystic fibrosis.

View Article and Find Full Text PDF

Type 1 cannabinoid receptors (CB1Rs) are widely expressed in the vertebrate retina, but the role of endocannabinoids in vision is not fully understood. Here, we identified a novel mechanism underlying a CB1R-mediated increase in retinal ganglion cell (RGC) intrinsic excitability acting through AMPK-dependent inhibition of NKCC1 activity. Clomeleon imaging and patch clamp recordings revealed that inhibition of NKCC1 downstream of CB1R activation reduces intracellular Cl(-) levels in RGCs, hyperpolarizing the resting membrane potential.

View Article and Find Full Text PDF

Opioid dependence is accompanied by neuroplastic changes in reward circuitry leading to a negative affective state contributing to addictive behaviors and risk of relapse. The current study presents a neuroimmune mechanism through which chronic opioids disrupt the ventral tegmental area (VTA) dopaminergic circuitry that contributes to impaired reward behavior. Opioid dependence was induced in rodents by treatment with escalating doses of morphine.

View Article and Find Full Text PDF

Chronic pain attenuates midbrain dopamine (DA) transmission, as evidenced by a decrease in opioid-evoked DA release in the ventral striatum, suggesting that the occurrence of chronic pain impairs reward-related behaviors. However, mechanisms by which pain modifies DA transmission remain elusive. Using in vivo microdialysis and microinjection of drugs into the mesolimbic DA system, we demonstrate in mice and rats that microglial activation in the VTA compromises not only opioid-evoked release of DA, but also other DA-stimulating drugs, such as cocaine.

View Article and Find Full Text PDF

More than 1.5 billion people worldwide suffer from chronic pain, yet current treatment strategies often lack efficacy or have deleterious side effects in patients. Adenosine is an inhibitory neuromodulator that was previously thought to mediate antinociception through the A1 and A2A receptor subtypes.

View Article and Find Full Text PDF